Welcome to YSD International, a pharmaceutical company based in United Arab Emirates.

Immunotherapy

Trastuzumab is indicated for

  • Adjuvant Breast Cancer
  • Metastatic Breast Cancer
  • Gastric Cancer

Bevacizumab is a tumor-starving (anti-angiogenic) therapy. Bevacizumab is designed to block a protein called vascular endothelial growth factor, or VEGF. Bevacizumab is indicated for

  • Metastatic Colorectal Cancer (mCRC)
  • Non–Small Cell Lung Cancer (nsNSCLC)
  • Glioblastoma (GBM)
  • Metastatic Kidney Cancer (mRCC)
  • Advanced Cervical Cancer (CC)
  • Ovarian Cancer (OC)
  • Hepatocellular Carcinoma (HCC)

Rituximab is a prescription medicine used to treat:

  • Non-Hodgkin’s Lymphoma (NHL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Rheumatoid arthritis (RA)
  • Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
  • Pemphigus Vulgaris (PV)